Compare Novartis AG (NVS) vs ON Holding AG (ONON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs ON Holding AG — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while ON Holding AG trades at $37.31 (market cap $12.55B). The key difference: Novartis AG is far larger — about 23.1× ON Holding AG's market cap, and Novartis AG pays a 3.17% dividend while ON Holding AG pays none. Which is the better fit depends on your goals.
| NVS | ONON | |
|---|---|---|
Market Cap | $290.25B | $12.55B |
Sector | Health | Technology |
52-Week High | $168.62 | $53.21 |
52-Week Low | $113.50 | $31.88 |
Enterprise Value | $330.27B | $11.87B |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About ON Holding AG
ON Holding AG is a Swiss sports company primarily known for its high-performance running shoes, apparel, and accessories under the 'On' brand. The company emphasizes a blend of high-end design, proprietary cloud technology (like CloudTec cushioning), and sustainability in its products. On has rapidly gained market share globally, appealing to both competitive athletes and general consumers in the performance and lifestyle footwear segments.
Read more on ONON →
